Home » Newsletters » BioWorld Asia

BioWorld Asia

April 28, 1999

View Archived Issues

Sugens European Subsidiary To Advance Cancer Drugs

Villainous H. Pylori Found To Contain Antibacterial, May Guard Against Cholera

CeNeS In-Licenses Stroke Drug From Glaxo Wellcome

GeneScan Europe Is On A Fast Track To Chip-Based Diagnostics

Alizyme Picks Lead Drug: Obesity Lipase Inhibitor

Fact-Finding Bid Seeks To Maintain U.K.s Edge

NeuroVir Moving Facility; Cites Better Growth Options

IntroGene, Tibotec Establish JV For Functional Genomics

D-Pharms Epilepsy Drug Moves Into Phase I Trials

Money Clock Running On Hyals Debentures

Scotia Signs Galactosome Deal With Bristol-Myers

Organon, Epitope In Collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...